Rugby Football Union (RFU) v Leigh Dearden

To optimise for archiving, the original image and related documents associated with this article have been removed.

A decision in the case of the Rugby Football Union (RFU) v Leigh Dearden has been published by the National Anti-Doping Panel (NADP). 

On 23 March 2019 Leigh Dearden, a player registered with Lincoln RFC and the RFU, provided a urine sample.  The urine sample returned Adverse Analytical Findings for Drostanolone and a metabolite, 2 metabolites of Oxymetholone, and cocaine metabolite benzoylecgonine.  Mr Dearden was subsequently charged with a breach of World Rugby Regulation 21.2.1 for the Presence of Prohibited Substances or their Metabolites or Markers on 31 May 2019.

Mr Dearden did not dispute the Anti-Doping Rule Violation (ADRV) and the NADP Tribunal, consisting of Christopher Quinlan QC, Blondel Thompson and Professor Dorian Haskard imposed a period of ineligibility of 4 years, running from 31 May 2019 until midnight on 30 May 2023.

A copy of the full decision can be accessed via the related links tab on the right-hand side.

The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping who is responsible for investigating, charging and prosecuting cases before the NADP.

You may also like

View All

US Open utilises AI for 3D tennis and commentary

US Open has introduced AI technology which allows fans to watch a 3D cartoon version of top tennis players during matches and to also converse with a chatbot that provides commentary, whilst avoiding drama

Read More

ITIA v Arslanbek Aitkulov

A decision in the case of International Tennis Integrity Agency (ITIA) against Arslanbek Aitkulov has been issued by the Independent Panel

Read More

Enhanced Games sues World Aquatics, WADA and USA Swimming for $800m

The privately funded 2026 Enhanced Games set to take place in Las Vegas allows athletes to use performance enhancing substances without being subject to drug tests. It is now suing World Aquatics, the World Anti-Doping Agency and USA Swimming for $800m after accusing them of orchestrating an unlawful effort to discourage athletes from participating

Read More